Astellas Pharma Inc. is a global life sciences company established in 2005. The company focuses on developing and delivering therapies for critical unmet medical needs across several key therapeutic areas, including oncology, ophthalmology, urology, immunology, and women's health. Its operational philosophy centers on patient-centricity.
Astellas maintains a significant global presence, with headquarters in Tokyo, Japan, and major research and corporate hubs in Tsukuba, Japan, and Cambridge, Massachusetts. The company operates across the Americas, Europe, and Asia. Its research efforts are concentrated in advanced technical domains such as stem cell technology, gene editing, cell therapy, and targeted protein degradation.
